Aytu Biopharma (AYTU) EBT Margin Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) EBT Margin Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -691.00 |
| Sep 30, 2025 | 4,600.00 |
| Jun 30, 2025 | -7,946.00 |
| Mar 31, 2025 | 8,607.00 |
| Dec 31, 2024 | 17,288.00 |
| Sep 30, 2024 | 35,150.00 |
| Jun 30, 2024 | 24,955.00 |
| Mar 31, 2024 | 17,637.00 |
| Dec 31, 2023 | 26,809.00 |
| Sep 30, 2023 | 20,207.00 |
| Jun 30, 2023 | 48,665.00 |
| Mar 31, 2023 | 120,700.00 |
| Dec 31, 2022 | 37,321.00 |
| Sep 30, 2022 | 41,970.00 |
| Jun 30, 2022 | 74,895.00 |
| Mar 31, 2022 | 33,269.00 |
| Dec 31, 2021 | 52,760.00 |
| Sep 30, 2021 | 78,666.00 |
| Jun 30, 2021 | 155,227.00 |
| Dec 31, 2020 | 64,732.00 |